| Authors: |
Meth EMS; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Nôga DA; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Wedzinga F; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Almajni A; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Pacheco AP; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden.; Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, Oslo, 0372, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Postboks 1039 Blindern, Oslo, 0315, Norway., Rossi V; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Simonsson PC; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Heel C; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Zetterlund C; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Noory SFM; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Danek M; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden., Xue P; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden. pei.xue@uu.se., Benedict C; Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, Box 593, Uppsala, 751 24, Sweden. christian.benedict@uu.se. |
